Cargando…
The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy
A major difficulty in the treatment of cancers is the poor response of many tumors to pharmacological regimens. This situation can be accounted for by the existence of a variety of complex mechanisms of chemoresistance (MOCs), leading to reduced intracellular concentrations of active agents, changes...
Autores principales: | Marin, Jose JG, Monte, Maria J, Blazquez, Alba G, Macias, Rocio IR, Serrano, Maria A, Briz, Oscar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880477/ https://www.ncbi.nlm.nih.gov/pubmed/24317012 http://dx.doi.org/10.1038/aps.2013.131 |
Ejemplares similares
-
Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1
por: Herraez, Elisa, et al.
Publicado: (2017) -
Mechanisms of Anticancer Drug Resistance in Hepatoblastoma
por: Marin, Jose J. G., et al.
Publicado: (2019) -
Role of Intracellular Drug Disposition in the Response of Acute Myeloid Leukemia to Cytarabine and Idarubicin Induction Chemotherapy
por: Rodríguez-Macías, Gabriela, et al.
Publicado: (2023) -
Molecular Bases of Drug Resistance in Hepatocellular Carcinoma
por: Marin, Jose J.G., et al.
Publicado: (2020) -
Models for Understanding Resistance to Chemotherapy in Liver Cancer
por: Marin, Jose J. G., et al.
Publicado: (2019)